P/E ratio for Phibro Animal Health (PAHC)
P/E ratio as of April 2024 (TTM): 18.6
According to Phibro Animal Health 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 18.6056. At the end of 2022 the company had a P/E ratio of 14.9.
P/E ratio history for Phibro Animal Health from 2014 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 14.9 | -4.41% |
| 2021 | 15.6 | -12.51% |
| 2020 | 17.8 | -32.55% |
| 2019 | 26.4 | 48.67% |
| 2018 | 17.8 | -17.26% |
| 2017 | 21.5 | 10.67% |
| 2016 | 19.4 | 25.58% |
| 2015 | 15.5 | -70.62% |
| 2014 | 52.6 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | 138 | 643.22% | 🇺🇸 USA |
 Archer Daniels Midland (ADM)
ADM | 8.39 | -54.90% | 🇺🇸 USA |
 Zoetis ZTS | 30.4 | 63.61% | 🇺🇸 USA |
 Merck MRK | 69.3 | 272.31% | 🇺🇸 USA |
 Kindred Biosciences
KIN | N/A | N/A | 🇺🇸 USA |
 Heska Corporation
HSKA | -62.2 | -434.15% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.